Search

Author/Creator Genovese, M C

1. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Issue 01 (17th March 2009)

Authors:
Jones, G; Sebba, A; Gu, J; Lowenstein, M B; Calvo, A; Gomez-Reino, J J; Siri, D A; Tomšič, M; Alecock, E; Woodworth, T; Genovese, M C
Journal:
Annals of the rheumatic diseases
Issue:
Volume 69:Issue 01(2010)
Page Start:
88
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy. Issue 4 (5th October 2007)

Authors:
Genovese, M C; Schiff, M; Luggen, M; Becker, J-C; Aranda, R; Teng, J; Li, T; Schmidely, N; Le Bars, M; Dougados, M
Journal:
Annals of the rheumatic diseases
Issue:
Volume 67:Issue 4(2008)
Page Start:
547
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study. Issue 6 (9th December 2008)

Authors:
Keystone, E C; Genovese, M C; Klareskog, L; Hsia, E C; Hall, S T; Miranda, P C; Pazdur, J; Bae, S-C; Palmer, W; Zrubek, J; Wiekowski, M; Visvanathan, S; Wu, Z; Rahman, M U
Journal:
Annals of the rheumatic diseases
Issue:
Volume 68:Issue 6(2009)
Page Start:
789
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies. Issue 2 (3rd April 2008)

Authors:
Keystone, E; Emery, P; Peterfy, C G; Tak, P P; Cohen, S; Genovese, M C; Dougados, M; Burmester, G R; Greenwald, M; Kvien, T K; Williams, S; Hagerty, D; Cravets, M W; Shaw, T
Journal:
Annals of the rheumatic diseases
Issue:
Volume 68:Issue 2(2009)
Page Start:
216
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial. Issue 11 (15th December 2008)

Authors:
Schiff, M; Pritchard, C; Huffstutter, J E; Rodriguez-Valverde, V; Durez, P; Zhou, X; Li, T; Bahrt, K; Kelly, S; Le Bars, M; Genovese, M C
Journal:
Annals of the rheumatic diseases
Issue:
Volume 68:Issue 11(2009)
Page Start:
1708
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗